The stock of Synchrony Financial (SYF) decreased by -3.10% to finish the standard trading session at $27.50. During that period, a total of 5731698 shares were traded, and this stock’s average trading volume is currently 5.24M shares per day. Important things to pay attention to when considering a stock’s current and future price are the 52-week high and low price points. Shares of Synchrony Financial (SYF) are currently -27.97% below their 52-week high mark and 126.34% higher than the 52-week low mark.
The Vanguard Group, Inc. opened a new position with shares of Synchrony Financial (SYF) during the lastest quarter, according to the public company’s latest Form 13F filing with the US Securities and Exchange Commission (SEC). This particular institutional investor became the owner of 63,134,180 shares of the Credit Services provider’s common stock, which is currently worth approximately $1.57 billion. According to the latest SEC filing from The Vanguard Group, Inc., the firm held approximately 10.82% of Synchrony Financial. On a separate note, Capital Research & Management Co…. entered a new position in Synchrony Financial stock during the lastest quarter, holdings valued at $1.07 billion.
Turning now to this publicly-traded company’s past performance, we will explore different moving trends for SYF. This stock gained 7.63% during the last week and rose 5.08% over the last one-month period. Shares of this organization’s stock rose 23.21% throughout the last quarter. Within the last six months, the stock has increased 70.60%, with a full-year loss of -15.18%. At the time of writing, this stock’s year-to-date (YTD) price performance is now negative at -23.63%.
Out of a total of 20 brokerages that are currently covering Synchrony Financial (SYF) stock, the average recommendation is “Overweight” according to WSJ. 0 equities research analyst has rated the stock with a “Overweight” recommendation, 14 analysts have given this stock a “Buy” recommendation, 6 analysts have recommended that investors “Hold” this stock, and 0 analysts have given this stock a “Sell” rating and 0 suggested “Underweight”. Analysts’ average 1-year price target, among all the brokerages, is $29.61.
Shares of Physicians Realty Trust (DOC) managed to reach a high of $18.75 and dropped down to a low of $18.23, before this stock settled at $18.41 at the end of the latest trading session. This organization’s stock has been displaying bullish momentum. Its Average True Range, or ATR, has fallen consistently after each of the most recent 14 trading sessions. Stock traders typically look at the ATR when they want to focus on technical analysis. At the time of writing, the 14-day ATR for Physicians Realty Trust (DOC) is sitting at 0.53. Physicians Realty Trust currently has a 52-week low of $11.01 with a 52-week high of $20.78. This organization has a debt-to-equity ratio of 0.50. This public company has a market cap of $3.71 billion, a beta of 0.76, a price-to-earnings-growth ratio of 4.19, and price-to-earnings ratio of 40.64.
BLACK ALBERT JR, the Director of Physicians Realty Trust (DOC), bought 2,800 shares of Physicians Realty Trust stock in an exchange that took place on Aug 28. The shares were bought at an average price of $18.13 each, amounting to a total Buy worth $50,764. As of the close of the Buy, the Director now directly holds 48,963 shares of the organization’s stock, which is now worth about $901408.83. The deal was disclosed in a Securities & Exchange Commission legal filing, which can be publicly viewed on the SEC website.
Physicians Realty Trust (DOC) most recently publicly disclosed its earnings results on August 06, 2020. The organization posted $0.09 earnings per share (EPS) during the three-month period, which was $0.02 higher than the consensus estimate of $0.07. The company experienced a positive return on equity of 3.50% and a positive net margin of 20.30%. Physicians Realty Trust reported revenue of $431.50M during the last year. During the year-ago, the company reported $0.45 EPS. Analysts forecast that Physicians Realty Trust will report EPS of $0.08 for the current fiscal year.
Stock traders are taking a renewed look at shares of Physicians Realty Trust. This stock’s current 14-day RSI is standing at 55.73%, with a 9-day RSI of 59.40%, and a 20-day RSI of 54.21%. The RSI, which stands for Relative Strength Index, is a widely-used oscillating indicator trusted by investors and traders alike. The RSI works within a range-bound space with values on a scale from 0 to 100. When the RSI line rises, the shares may be showing strength. The contrary is the case when the RSI line starts to fall. When using the RSI indicator, different time periods may be looked at. When using a shorter time frame, the RSI might be more volatile. A lot of traders keep their focus between the 30 and 70 marks on the RSI scale. A shift higher than 70 is widely-considered to demonstrate that the stock has entered overbought territory. Meanwhile, a drop below 30 indicates that it may be in oversold territory. Traders often use these levels to predict stock price reversals.